Clinical Trial Update: Risks for Insulin Resistance and Metabolic Syndrome Between Major Depressive Disorder (MDD) or MDD With Psychotic Features

View source ↗

Summary

This terminated clinical trial investigated the risk of insulin resistance and metabolic syndrome in individuals with major depressive disorder, with or without…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Major Depressive Disorder with Psychotic Features
• Metabolic Syndrome

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Major Depressive Disorder, Major Depressive Disorder w/ Psychotic Features | Status: TERMINATED